• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙队列中高度近视对视力残疾的影响及其原因

Impact of high myopia on visual disability and its causes in a Spanish cohort.

作者信息

Arlanzon-Lope Pablo, Fernandez-Pedruelo Daniel, Alvarez-Arauzo Belén, Cuadrado-Asensio Ruben, Del Alamo-Martin Maria Teresa, Coco-Martin Rosa Maria

机构信息

Grupo de Investigación de Retina, Instituto de OftalmoBiología Aplicada (IOBA), Departamento de Cirugía, Oftalmología, Otorrinolaringología y Fisioterapia, (Facultad de Medicina), Universidad de Valladolid, Valladolid, Spain.

Grupo de Investigación de Retina, Instituto de OftalmoBiología Aplicada (IOBA), Departamento de Cirugía, Oftalmología, Otorrinolaringología y Fisioterapia, (Facultad de Medicina), Universidad de Valladolid, Valladolid, Spain.

出版信息

J Optom. 2025 Aug 9;18(4):100571. doi: 10.1016/j.optom.2025.100571.

DOI:10.1016/j.optom.2025.100571
PMID:40784190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12357106/
Abstract

PURPOSE

To evaluate visual disability (VD) and associated functional limitations in a Spanish High Myopia (HM) cohort using various disability scales and to identify the main causes of this disability and its impact on daily life.

METHODS

This observational study reviewed HM (spherical equivalent (SE)≤-6 D) adults clinical records at IOBA from January 2023 to June 2024. Exclusion criteria included incomplete data and having different pathologies other than pathologic myopia. VD was classified using ICD-10, ICD-11, and Wecker scales. R was used for statistical analysis.

RESULTS

We analysed 600 eyes from 300 patients (73.7 % women, mean age 57.6 ± 15.3 years, mean SE -13.04 ± 6.03 D, mean LogMAR visual acuity 0.52 ± 0.72). According to ICD-11, 7.6 % had mild VD, 12.3 % moderate, 4.7 % severe, and 2.7 % were blind. Wecker scale showed 46.7 % had VD. VD patients were older (p-value= 5.81 × 10) and had more negative SE (p-value=7.96 × 10). No sex differences in VD or pathology frequency were found. Myopic macular atrophy (MMA) (OR=7.816), retinal detachment (OR=3.956), amblyopia (OR=3.455), neovascularization (OR=2.668), SE (OR=1.115), and age (OR=1.040) were statistically significant key factors (p-value<0.05) for greater VD.

CONCLUSION

This study highlights a significant VD in a Spanish HM cohort being MMA the main cause. Age and SE were found to be relevant factors, as well.This helps to indentify patients more in need of visual rehabilitation.

摘要

目的

使用多种残疾量表评估西班牙高度近视(HM)队列中的视力残疾(VD)及相关功能限制,并确定这种残疾的主要原因及其对日常生活的影响。

方法

这项观察性研究回顾了2023年1月至2024年6月在IOBA的HM(等效球镜(SE)≤-6 D)成人临床记录。排除标准包括数据不完整以及患有除病理性近视以外的其他疾病。使用ICD-10、ICD-11和韦克量表对VD进行分类。使用R进行统计分析。

结果

我们分析了300名患者的600只眼(73.7%为女性,平均年龄57.6±15.3岁,平均SE -13.04±6.03 D,平均LogMAR视力0.52±0.72)。根据ICD-11,7.6%有轻度VD,12.3%为中度,4.7%为重度,2.7%为失明。韦克量表显示46.7%有VD。VD患者年龄较大(p值=5.81×10)且SE更负(p值=7.96×10)。在VD或病理频率方面未发现性别差异。近视性黄斑萎缩(MMA)(OR=7.816)、视网膜脱离(OR=3.956)、弱视(OR=3.455)、新生血管形成(OR=2.668)、SE(OR=1.115)和年龄(OR=1.040)是导致更大VD的统计学显著关键因素(p值<0.05)。

结论

本研究强调西班牙HM队列中存在显著的VD,MMA是主要原因。年龄和SE也是相关因素。这有助于识别更需要视力康复的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc0/12357106/ea65c550d096/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc0/12357106/e1fdae19d190/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc0/12357106/346e87e4f6ad/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc0/12357106/a86f54c70a0c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc0/12357106/ea65c550d096/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc0/12357106/e1fdae19d190/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc0/12357106/346e87e4f6ad/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc0/12357106/a86f54c70a0c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc0/12357106/ea65c550d096/gr4.jpg

相似文献

1
Impact of high myopia on visual disability and its causes in a Spanish cohort.西班牙队列中高度近视对视力残疾的影响及其原因
J Optom. 2025 Aug 9;18(4):100571. doi: 10.1016/j.optom.2025.100571.
2
Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.抗血管内皮生长因子用于病理性近视患者脉络膜新生血管化的治疗
Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD011160. doi: 10.1002/14651858.CD011160.pub2.
3
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.抗血管内皮生长因子治疗糖尿病性黄斑水肿:一项网状Meta分析。
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD007419. doi: 10.1002/14651858.CD007419.pub5.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Laser-assisted subepithelial keratectomy (LASEK) versus laser-assisted in-situ keratomileusis (LASIK) for correcting myopia.准分子激光上皮下角膜磨镶术(LASEK)与准分子激光原位角膜磨镶术(LASIK)治疗近视的比较。
Cochrane Database Syst Rev. 2017 Feb 15;2(2):CD011080. doi: 10.1002/14651858.CD011080.pub2.
6
Surgical interventions for bilateral congenital cataract in children aged two years and under.儿童两岁及以下双侧先天性白内障的手术干预。
Cochrane Database Syst Rev. 2022 Sep 15;9(9):CD003171. doi: 10.1002/14651858.CD003171.pub3.
7
Interventions to increase time spent outdoors for preventing incidence and progression of myopia in children.增加儿童户外活动时间以预防近视发生和进展的干预措施。
Cochrane Database Syst Rev. 2024 Jun 12;6(6):CD013549. doi: 10.1002/14651858.CD013549.pub2.
8
Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia.准分子激光上皮下角膜磨镶术(LASEK)与准分子激光角膜切削术(PRK)矫正近视的对比
Cochrane Database Syst Rev. 2016 Feb 22;2(2):CD009799. doi: 10.1002/14651858.CD009799.pub2.
9
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.预防性使用非甾体抗炎药预防白内障手术后黄斑水肿。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD006683. doi: 10.1002/14651858.CD006683.pub3.
10
Blue-light filtering spectacle lenses for visual performance, sleep, and macular health in adults.蓝光滤光眼镜在成人的视觉表现、睡眠和黄斑健康方面的应用。
Cochrane Database Syst Rev. 2023 Aug 18;8(8):CD013244. doi: 10.1002/14651858.CD013244.pub2.

本文引用的文献

1
Prevalence and Cause of Loss of Visual Acuity and Visual Field in Highly Myopic Eyes: The Beijing Eye Study.高度近视眼中视力和视野丧失的患病率和原因:北京眼研究。
Ophthalmology. 2024 Jan;131(1):58-65. doi: 10.1016/j.ophtha.2023.08.026. Epub 2023 Sep 9.
2
Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States.美国商业保险近视人群孔源性视网膜脱离的流行病学。
Sci Rep. 2023 Jun 9;13(1):9430. doi: 10.1038/s41598-023-35520-x.
3
Differences in anterior peripheral pathologic myopia and macular pathologic myopia by age and gender.
前部周边病理性近视与黄斑部病理性近视在年龄和性别上的差异。
Graefes Arch Clin Exp Ophthalmol. 2021 Nov;259(11):3511-3513. doi: 10.1007/s00417-021-05217-w. Epub 2021 May 21.
4
IMI Pathologic Myopia.病理性近视
Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):5. doi: 10.1167/iovs.62.5.5.
5
Progression of myopic maculopathy in a Caucasian cohort of highly myopic patients with long follow-up: a multistate analysis.白种人高度近视患者队列中近视性黄斑病变的进展及长期随访:一项多状态分析
Graefes Arch Clin Exp Ophthalmol. 2021 Jan;259(1):81-92. doi: 10.1007/s00417-020-04795-5. Epub 2020 Jun 20.
6
Visual impairment in highly myopic eyes: The ZOC-BHVI High Myopia Cohort Study.高度近视眼中的视力损害:ZOC-BHVI 高度近视队列研究。
Clin Exp Ophthalmol. 2020 Aug;48(6):783-792. doi: 10.1111/ceo.13779. Epub 2020 Jun 8.
7
IMI - Clinical Management Guidelines Report.IMI - 临床管理指南报告。
Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M184-M203. doi: 10.1167/iovs.18-25977.
8
IMI - Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies.IMI - 定义和分类近视:临床和流行病学研究的一套标准建议。
Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M20-M30. doi: 10.1167/iovs.18-25957.
9
Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling.全球与近视性黄斑变性相关的视力障碍患病率及 2000 年至 2050 年的时间趋势:系统评价、荟萃分析和建模。
Br J Ophthalmol. 2018 Jul;102(7):855-862. doi: 10.1136/bjophthalmol-2017-311266. Epub 2018 Apr 26.
10
Public Health Burden and Potential Interventions for Myopia.近视的公共卫生负担与潜在干预措施
Ophthalmology. 2018 May;125(5):628-630. doi: 10.1016/j.ophtha.2018.01.033.